Загрузка...
Comparing the Efficacy, Safety, and Superiority of Calcitonin Gene-Related Peptide Monoclonal Antibodies and Botox in Preventing and Treating Migraines
Both calcitonin gene-related peptide (CGRP) monoclonal antibodies (mAbs) and OnabotulinumtoxinA (botox) are used in the prevention of chronic migraines. However, it is not clear which is more effective overall. This review will compare the efficacy, side effects, cost-effectiveness, and other factor...
Сохранить в:
| Опубликовано в: : | Cureus |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Cureus
2021
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7847775/ https://ncbi.nlm.nih.gov/pubmed/33542885 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.13002 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|